Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
san francisco blog main
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
amgen
athena countouriotis
biotech
boston blog main
boston top stories
brett zbar
bristol-myers squibb
cholesterol
clinical trials
cormorant asset management
daiichi sankyo
data
halozyme therapeutics
hbm healthcare investments
hbm partners
inclisiran
jean cui
ldl
lilly asia ventures
mark timney
mt sinai hospital
new york
new york blog main
new york top stories
nextech invest
orbimed advisors
pcsk9
peter li
peter wijngaard
pfizer
praluent
prashant vaishnava
quizartinib
What
ceo
2
×
drug
2
×
year
2
×
aces
announced
athena
big
biotech
cancer
chief
cholesterol
countouriotis
financing
flexible
gets
inclisiran
key
lowering
meant
medco
medical
medicine
medicines
mezzanine
million
names
nasdaq
new
officer
old
open
passed
pricing
promoted
push
raised
round
taken
test
therapeutics
Language
unset
Current search:
drug
×
year
×
ceo
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
